Biological Agents and Therapeutic Plasma Exchange: Can They Coexist in the Future? - Wikidata - wikimedia - TriplyDB

Biological Agents and Therapeutic Plasma Exchange: Can They Coexist in the Future?

Biological Agents and Therapeutic Plasma Exchange: Can They Coexist in the Future?

http://www.wikidata.org/entity/Q47800187

about

Biological Agents and Therapeutic Plasma Exchange: Can They Coexist in the Future?

http://www.wikidata.org/entity/Q47800187

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Biological Agents and Therapeutic Plasma Exchange: Can They Coexist in the Future?

@en

Biological Agents and Therapeutic Plasma Exchange: Can They Coexist in the Future?

@nl

type

label

Biological Agents and Therapeutic Plasma Exchange: Can They Coexist in the Future?

@en

Biological Agents and Therapeutic Plasma Exchange: Can They Coexist in the Future?

@nl

prefLabel

Biological Agents and Therapeutic Plasma Exchange: Can They Coexist in the Future?

@en

Biological Agents and Therapeutic Plasma Exchange: Can They Coexist in the Future?

@nl

P1433

Q47800187-6A7D33E5-6D1C-4490-A6E8-FD27FF925598

P1476

Q47800187-1BEFD1BA-1191-4C38-9FA2-6CFA96A9AAF7

P2860

Q47800187-097E33B6-3F3C-4009-BCF3-DA392C7E962A

Q47800187-12318535-1650-41FF-A2C4-5F13FEE14070

Q47800187-5DEB8EEE-6287-4778-8FFE-DE9FADC66843

Q47800187-735528EC-3DC5-4B28-8ECE-86EF03231689

Q47800187-766C5033-B50A-46C1-85EE-8119F412D094

Q47800187-860C9E67-D160-4122-B496-C4747B68849D

Q47800187-8AB90CAD-D61D-4D1D-A5CC-3A774AFE1DA7

Q47800187-947825CD-F492-4817-9A50-0D1AB47F0266

Q47800187-976308C1-BD20-4B10-9142-77A19A2033DF

Q47800187-9AE1A0E8-5EF9-4305-86A6-4898EF80302F

P304

Q47800187-186773FF-D7B7-47F5-8950-97A5F4C69716

P31

Q47800187-9d31df7e-5e69-4f35-ba8e-e922811d13f2

Q47800187-D8C71E5A-A479-44B4-8D8E-E63B7B65745E

P356

Q47800187-DB882232-3303-449B-9251-124D61AF750B

P433

Q47800187-5F53A5AE-E78C-4D36-AB95-DFF12191AF1C

P478

Q47800187-224BB9CE-4586-405D-8EEC-AD62515AC4DC

P50

Q47800187-DD27DDE3-550A-440B-9A29-3AA397AE1EC2

P577

Q47800187-498094DE-DCE9-4F88-B73E-96A73263B11D

P698

Q47800187-59D4F12D-6E2E-42AE-8F78-83CFD7A5B414

P356

1744-9987.12639

P1433

Therapeutic Apheresis and Dialysis

P1476

Biological Agents and Therapeutic Plasma Exchange: Can They Coexist in the Future?

@en

P2860

FSGS Recurrence in Adults after Renal Transplantation

Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis.

Rituximab pharmacokinetics during the management of acute idiopathic thrombotic thrombocytopenic purpura.

Eculizumab in secondary atypical haemolytic uraemic syndrome.

Cryoglobulinemia Vasculitis.

A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation

Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial

Population pharmacokinetics of rituximab with or without plasmapheresis in kidney patients with antibody-mediated disease.

Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab.

Recurrent focal segmental glomerulosclerosis after kidney transplantation.

P304

553-555

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/1744-9987.12639

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

Andreas Kronbichler

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29205892

http://www.w3.org/2001/XMLSchema#string